Researchers have found that certain bacteria carry a naturally occurring system, built from repurposed CRISPR components, that switches genes on rather than cutting or silencing DNA. The discovery, reported in Nature, centers on a deactivated Cas12f protein fused with a sigma factor in the marine bacterium Flagellimonas taeanensis. The system recruits RNA polymerase to start transcription at specific sites, effectively bypassing the standard promoter signals that bacteria normally rely on to read their genes. The finding challenges a long-standing assumption: that CRISPR machinery in bacteria exists almost exclusively as a defense against viruses.
A CRISPR Module That Activates, Not Cuts
CRISPR systems are best known as the prokaryotic adaptive immune system, storing short DNA sequences from past invaders and using them to recognize and destroy returning threats. Those stored sequences, called spacers, are derived from mobile genetic elements such as bacteriophages, transposons, and plasmids. But the new work shows that at least one lineage of bacteria has co-opted, or “exapted,” a Cas12f protein for a completely different job. Instead of cleaving foreign DNA, the protein has lost its nuclease activity and gained the ability to physically recruit RNA polymerase (RNAP) to a target site on the bacterium’s own chromosome.
The key partner in this process is a sigma factor called sigma-E. In reporter assays described in the Nature study, the dCas12f–sigma fusion drove expression of red fluorescent protein (RFP), confirming that the complex can initiate transcription of a downstream gene. RNA-seq mapping pinpointed the transcription start site approximately 46 base pairs downstream of the guide RNA binding site, a fixed spacing that suggests a tightly defined mechanical relationship between where the complex lands and where reading begins. Because the guide RNA determines the docking site, this architecture effectively turns sequence-specific recognition into a programmable “on” switch.
Structural Snapshots of a Gene Switch in Action
A companion study used cryo-electron microscopy to capture the complex in several conformational states. Those structures, published in Nature, include a DNA-bound assembly of dCas12f, sigma-E, and RNAP holoenzyme from Flagellimonas taeanensis. The images show how the deactivated Cas protein physically docks with RNAP, positioning the polymerase so it can begin reading DNA without needing a traditional promoter element. That promoter bypass is significant because it means the system can, in principle, activate transcription at almost any genomic location where a guide RNA directs it, a degree of flexibility that standard bacterial gene regulation does not easily allow.
The structural data also helps explain the consistent 46 bp spacing observed in the functional assays. The physical architecture of the dCas12f–sigma-E–RNAP assembly essentially sets a ruler-like distance between the guide RNA’s landing pad and the point where transcription fires. This kind of fixed geometry is a hallmark of a system that has been refined by natural selection, not a random byproduct of protein interaction. It also offers a practical design rule: in principle, engineers could place guides at predictable offsets to tune where transcription starts in synthetic constructs.
Why Bacteria Were Assumed to Only Repress
For years, the dominant view held that when bacteria repurpose CRISPR components for gene regulation, they almost always turn genes down, not up. That assumption had solid experimental backing. Cas9, for example, has been shown to repress gene activity tied to bacterial virulence. David S. Weiss of Emory University previously found that some bacteria use Cas9 to silence their own genes, helping pathogens evade detection by a host’s immune system. A review of Type I CRISPR-Cas systems similarly concluded that most engineered bacterial regulators built from CRISPR parts function as repressors, particularly when researchers disable the Cas3 cleavage enzyme and let the Cascade complex sit on a promoter to block transcription.
The new findings from Flagellimonas taeanensis do not invalidate that body of work. Repression remains the more common documented role. But the discovery of a natural activator expands the known repertoire of what CRISPR-derived systems can do inside a living cell, and it raises a pointed question: how many other bacteria carry similar exapted modules that have gone unnoticed because researchers were not looking for activation? Systematic mining of microbial genomes for dCas fusions to transcription factors could reveal additional families of such switches.
Engineered Activators Laid the Groundwork
The idea that CRISPR tools could switch genes on is not entirely new in synthetic biology. Earlier engineering efforts demonstrated that a catalytically dead Cas9 (dCas9) fused with modified scaffold RNAs could recruit activator domains like SoxS to specific promoter regions in bacteria, with activation strength depending on the precise position of the guide RNA relative to the promoter. Building on that principle, later work in E. coli used combinatorial scaffold RNA designs to run multi-gene activation programs, linking RNA folding kinetics to the level of gene expression achieved. Separately, assays with a miniature Cas12-family effector known as Cas12n in type V-N systems showed that even compact CRISPR proteins can drive reporter gene activation from plasmid-based setups in E. coli.
Those engineered platforms essentially anticipated what Flagellimonas taeanensis appears to have evolved on its own: a nuclease-dead effector physically tethered to a transcriptional activator. The difference is that natural selection has optimized the bacterial system for stability and precise geometry in its native context, whereas synthetic constructs often require careful tuning of expression levels, guide placement, and growth conditions to work reliably. Still, the parallels suggest that lessons from laboratory design can inform how researchers search for, and interpret, naturally occurring CRISPR activators.
Evolutionary Clues From Cas Diversity
The discovery also fits into a broader reevaluation of Cas protein diversity. Comparative genomics has revealed many compact and atypical effectors, such as the small Cas12-family nucleases that appear well suited to tight packaging in mobile elements or viral genomes. Some of these proteins have already been adapted as genome-editing tools due to their size and flexible targeting rules. The Flagellimonas system adds another twist: a miniature nuclease that has abandoned cutting altogether in favor of transcriptional control.
From an evolutionary standpoint, exaptation of CRISPR components for regulation is plausible because the underlying machinery already brings together guide RNAs, DNA recognition, and multi-protein assemblies. Once nuclease activity is lost, selection can favor mutations that strengthen interactions with RNAP or other regulators. Over time, this can yield dedicated modules whose primary role is gene expression control rather than immunity, blurring the boundary between defense and regulation in bacterial genomes.
Implications for Synthetic Biology and Gene Control
For synthetic biologists, a naturally evolved activator is more than a curiosity. It offers a template for building compact, programmable switches that may be easier to deliver into microbes than bulkier Cas9-based systems. The fixed 46 bp offset between binding and transcription start could be exploited as a predictable design parameter in genetic circuits, allowing engineers to place guide sites with base-pair precision to orchestrate timing and strength of expression.
There are also intriguing parallels to eukaryotic CRISPR activation systems. In mammalian cells, dCas9 has been fused to multiple activation domains to create robust transcriptional activators; one influential study used a SunTag peptide array to recruit many copies of VP64 and p65, boosting expression from targeted promoters and enabling multiplexed control of endogenous genes. Work along these lines, such as multi-component dCas9 activators, has shown that programmable recruitment of transcriptional machinery can rewire gene networks without altering DNA sequence. The Flagellimonas mechanism demonstrates that bacteria, too, can naturally deploy CRISPR-based recruitment rather than cleavage.
Looking ahead, researchers will want to know how widespread such systems are, what genes they control in their native hosts, and whether they can be ported into industrial strains or microbiome members without losing function. If additional examples emerge, they could form a toolbox of orthogonal activators, each with distinct spacing rules or sequence preferences, enabling finer-grained programming of microbial communities and bioproduction pathways. The Flagellimonas dCas12f–sigma module is thus both a window into bacterial evolution and a potential workhorse for the next generation of CRISPR-based gene switches.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
